<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03708705</url>
  </required_header>
  <id_info>
    <org_study_id>ZJUXU1177</org_study_id>
    <nct_id>NCT03708705</nct_id>
  </id_info>
  <brief_title>Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study</brief_title>
  <official_title>Liquid Biopsy-based Monitoring System for Relapse of Hepatocellular Carcinoma Associated With Hepatitis B After Liver Transplantation: A Multi-center and Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to develop a novel, reliable, liquid biopsy-based biomarker system for
      relapse of HCC associated with hepatitis B after liver transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Relapse of hepatocellular carcinoma (HCC) is one of the leading causes of death after liver
      transplantation (LT). Detection of cancer at an earlier stage of the disease can be critical
      to improve patient survival. Liquid biopsy is a revolutionary technique that is opening
      previously unexpected perspectives. It consists of circulating extracellular vesicles,
      nucleic acids (DNA and RNA) and circulating tumor cells. The detection and isolation of
      circulating tumor cells, circulating tumor DNA and exosomes, as a source of genomic and
      proteomic information in patients with cancer. Regarding these promising and potential
      transformative tools, as well as the issues still needed to be addressed for adopting various
      liquid biopsy approaches into clinical practice. This study aims to develop a novel,
      reliable, liquid biopsy-based biomarker system for relapse of HCC associated with hepatitis B
      after liver transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 20, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>relapse rate of tumor</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Relapse</arm_group_label>
    <description>Relapse of tumor within two years after liver transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-relapse</arm_group_label>
    <description>Non-relapse of tumor within two years after liver transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Risk model of tumor relapse</intervention_name>
    <description>High risk factor model of tumor relapse after liver transplantation</description>
    <arm_group_label>Non-relapse</arm_group_label>
    <arm_group_label>Relapse</arm_group_label>
    <other_name>Risk model</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and tissue samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        hospitalization patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        transplants for HCC

        Exclusion Criteria:

        Liver transplantation due to other disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 13, 2018</study_first_submitted>
  <study_first_submitted_qc>October 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>October 18, 2018</last_update_submitted>
  <last_update_submitted_qc>October 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhejiang University</investigator_affiliation>
    <investigator_full_name>Xiao Xu</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Two years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

